![Roelof Rongen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roelof Rongen
Direttore/Membro del Consiglio presso
GRI BIO, INC.
Patrimonio netto: - $ in data 31/08/2026
Profilo
Roelof Rongen is the founder of Matinas BioPharma, Inc., founded in 2011, serving as President, Chief Executive Officer & Director.
Mr. Rongen was the founder of Innovative Molecules GmbH, founded in 2019, serving as Chief Executive Officer.
Mr. Rongen is also the founder of Essential Fatty Acid Therapeutics LLC..
Mr. Rongen is Chief Executive Officer & Director at Adolore Biotherapeutics, Inc. since 2022.
Mr. Rongen is Independent Director at GRI Bio, Inc. since 2023.
Former positions include Chief Executive Officer & Director at Matinas BioPharma Holdings, Inc. from 2016 to 2018, Executive Director-Marketing at Logistics & Environmental Solutions Corp., Director at Vallon Pharmaceuticals, Inc., Vice President-Life Cycle Management at Reliant Pharmaceuticals LLC from 2000 to 2008, and Executive VP-North American Operations at Trygg Pharma AS from 2009 to 2012.
Education includes undergraduate studies at Wageningen University and an MBA from Kellogg School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GRI BIO, INC. -.--% | 17/01/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Posizioni attive di Roelof Rongen
| Società | Posizione | Inizio |
|---|---|---|
| GRI BIO, INC. | Direttore/Membro del Consiglio | 24/04/2023 |
Matinas BioPharma, Inc. | Fondatore | 11/08/2011 |
Essential Fatty Acid Therapeutics LLC | Fondatore | - |
Adolore Biotherapeutics, Inc.
 Adolore Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing novel therapies for the treatment of chronic, other pain and nervous system | Amministratore Delegato | 01/07/2022 |
Precedenti posizioni note di Roelof Rongen
| Società | Posizione | Fine |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Amministratore Delegato | 16/03/2018 |
Trygg Pharma AS
 Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Develops marine based omega-3 fatty acids for pharmaceutical applications | Corporate Officer/Principal | 01/01/2012 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2008 |
Innovative Molecules GmbH
 Innovative Molecules GmbH Pharmaceuticals: MajorHealth Technology Provides drug development services | Amministratore Delegato | - |
| GRI BIOPAR | Direttore/Membro del Consiglio | - |
Formazione di Roelof Rongen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
50
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Matinas BioPharma, Inc. | |
Matinas BioPharma Holdings, Inc.
 Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Logistics & Environmental Solutions Corp.
 Logistics & Environmental Solutions Corp. Air Freight/CouriersTransportation Provides logistics solutions for government and commercial markets | Transportation |
Trygg Pharma AS
Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Develops marine based omega-3 fatty acids for pharmaceutical applications | Health Technology |
Wageningen University
 Wageningen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essential Fatty Acid Therapeutics LLC | |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Innovative Molecules GmbH
Innovative Molecules GmbH Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Adolore Biotherapeutics, Inc.
Adolore Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing novel therapies for the treatment of chronic, other pain and nervous system | Health Technology |
GRI Bio, Inc.
 GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
